Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Pharmova gains as US FDA closes inspection without urging action

** Shares of Jubilant Pharmova JUBA.NS jump 2% to 882.30 rupees

** U.S. FDA completes inspection of drugmaker's manufacturing site in Maryland, classifies it as "voluntary action indicated"

** VAI indicates the agency is not prepared to take or recommend any administrative or regulatory action, per the FDA website

** Stock down 21% this year after doubling in 2024

 (Reporting by Nandan Mandayam in Bengaluru)

 ((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))

Recent news on Jubilant Pharmova

See all news